DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Encainide

Encainide

  • Second Generation Antiarrhythmic Agents: Have We Reached Antiarrhythmic Nirvana?

    Second Generation Antiarrhythmic Agents: Have We Reached Antiarrhythmic Nirvana?

  • Formulation Development Strategies

    Formulation Development Strategies

  • ACC/AHA/ESC Practice Guideline

    ACC/AHA/ESC Practice Guideline

  • Compounds and Bulk Powders

    Compounds and Bulk Powders

  • Draft for Public Comment

    Draft for Public Comment

  • Cordarone (Amiodarone Hydrochloride)

    Cordarone (Amiodarone Hydrochloride)

  • Treatment of Atrioventricular Node Reentrant Tachycardia with Encainide: Reversal of Drug Effect with Isoproterenol

    Treatment of Atrioventricular Node Reentrant Tachycardia with Encainide: Reversal of Drug Effect with Isoproterenol

  • MEXITIL® (Mexiletine Hydrochloride, USP) Is an Orally Active Antiarrhythmic Agent Available As 150 Mg, 200 Mg and 250 Mg Capsules

    MEXITIL® (Mexiletine Hydrochloride, USP) Is an Orally Active Antiarrhythmic Agent Available As 150 Mg, 200 Mg and 250 Mg Capsules

  • Medications to Avoid in Long QT Syndrome

    Medications to Avoid in Long QT Syndrome

  • Get in Rhythm with the Safe and Effective Use of Antiarrythmic Drugs

    Get in Rhythm with the Safe and Effective Use of Antiarrythmic Drugs

  • Possible Encainide-Induced Hypoproteinemia

    Possible Encainide-Induced Hypoproteinemia

  • Egdb1de1.Pdf

    Egdb1de1.Pdf

  • Structural Basis for Antiarrhythmic Drug Interactions with the Human Cardiac Sodium Channel

    Structural Basis for Antiarrhythmic Drug Interactions with the Human Cardiac Sodium Channel

  • Effect of Mexiletine on Muscle Stiffness In

    Effect of Mexiletine on Muscle Stiffness In

  • POCKET GUIDE of DRUG INTERACTIONS Second Edition

    POCKET GUIDE of DRUG INTERACTIONS Second Edition

  • Pharmaabkommen A1 E

    Pharmaabkommen A1 E

  • Drug-Induced QT-Interval Prolongation and Proarrhythmic Risk

    Drug-Induced QT-Interval Prolongation and Proarrhythmic Risk

  • ECG Manifestations: the Poisoned Patient Christopher P

    ECG Manifestations: the Poisoned Patient Christopher P

Top View
  • Management of Drug Overdose and Poisoning
  • Comparative Study of Encainide and Quinidine in the Treatment of Ventricular Arrhythmias
  • Clinician's Pocket Drug Reference 2015
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • Namuscla, INN-Mexiletine
  • Encainide and Its Metabolites. Comparative Effects in Man on Ventricular Arrhythmia and Electrocardiographic Intervals
  • Particular Reference to Class I Antiarrhythmic Agents
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • TOXINS and DRUGS REPORTED to INDUCE SEIZURES Resource Library > Tables > Toxins and Drugs Reported to Induce Seizures
  • IA Hotline0112sodium Channel
  • Genetic and Biological Markers in Drug Abuse and Alcoholism
  • Winek's Drug & Chemical Blood-Level Data 2001
  • Diltiazem Teva 
  • Dilatam ®120 Sr
  • Interaction of Ischaemia and Encainide/Flecainide
  • NEW RYTHMOL SR (Propafenone Hydrochloride)
  • DRUG USE REVIEW BOARD Date of Posting
  • Cytochrome P450 Drug Interactions CYP1A2 ---Substrates---Inhibitors---Inducers-- CYP2C9 ---Subst


© 2024 Docslib.org    Feedback